The Goldman Sachs Group Cuts Ginkgo Bioworks (NYSE:DNA) Price Target to $1.10 : vimarsana.com

Ginkgo Bioworks (NYSE:DNA – Free Report) had its target price reduced by The Goldman Sachs Group from $1.25 to $1.10 in a research note published on Monday morning, Benzinga reports. They currently have a sell rating on the stock. Several other research analysts have also recently issued reports on the company. Raymond James cut Ginkgo […]

Related Keywords

Jasonr Kelly , Raymond James , Barry Canton , Aspen Grove Capital , Goldman Sachs Group , Advisor Group , Silverlake Wealth Management , Yousif Capital Management , Ginkgo Bioworks Holdings Inc , Securities Exchange Commission , Ginkgo Bioworks , Free Report , Bioworks Trading Down , Get Free Report , Exchange Commission , Capital Management , Wealth Management , Bioworks Holdings , Ginkgo Bioworks Daily , Nyse Dna , Dna , Medical , Lower Price Target , The Goldman Sachs Group Inc ,